BSE Live
Mar 25, 15:30Prev. Close
115.45
Open Price
117.80
Bid Price (Qty.)
121.00 (10)
Offer Price (Qty.)
123.80 (3)
NSE Live
Mar 25, 15:29Prev. Close
115.45
Open Price
116.00
Bid Price (Qty.)
121.99 (542)
Offer Price (Qty.)
122.50 (360)
| Key Financial Ratios of Kopran (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 3.89 | 4.36 | 3.09 | 1.58 | 1.32 | |
| Diluted EPS (Rs.) | 3.89 | 4.36 | 3.09 | 1.58 | 1.32 | |
| Cash EPS (Rs.) | 6.10 | 7.55 | 6.18 | 4.50 | 4.26 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 43.09 | 34.97 | 30.61 | 27.52 | 25.94 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 43.09 | 34.97 | 30.61 | 27.52 | 25.94 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 79.22 | 77.33 | 64.08 | 50.94 | 49.27 | |
| PBDIT/Share (Rs.) | 9.27 | 11.26 | 9.22 | 6.98 | 6.40 | |
| PBIT/Share (Rs.) | 6.94 | 8.07 | 6.13 | 4.05 | 3.52 | |
| PBT/Share (Rs.) | 3.77 | 4.36 | 3.09 | 1.58 | 1.31 | |
| Net Profit/Share (Rs.) | 3.77 | 4.36 | 3.09 | 1.58 | 1.38 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 11.70 | 14.55 | 14.39 | 13.69 | 12.98 | |
| PBIT Margin (%) | 8.75 | 10.43 | 9.56 | 7.95 | 7.14 | |
| PBT Margin (%) | 4.75 | 5.64 | 4.82 | 3.10 | 2.66 | |
| Net Profit Margin (%) | 4.75 | 5.64 | 4.82 | 3.10 | 2.80 | |
| Return on Networth / Equity (%) | 8.74 | 12.47 | 10.09 | 5.73 | 5.33 | |
| Return on Capital Employed (%) | 7.90 | 8.04 | 5.99 | 3.35 | 2.90 | |
| Return on Assets (%) | 5.63 | 5.17 | 4.11 | 2.20 | 2.03 | |
| Total Debt/Equity (X) | 0.15 | 0.85 | 0.79 | 0.89 | 1.02 | |
| Asset Turnover Ratio (%) | 118.56 | 91.78 | 85.38 | 71.18 | 72.36 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.45 | 1.37 | 1.34 | 1.09 | 1.14 | |
| Quick Ratio (X) | 2.28 | 0.92 | 0.94 | 0.72 | 0.74 | |
| Inventory Turnover Ratio (X) | 23.16 | 5.69 | 6.81 | 5.66 | 5.99 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 217.90 | 202.90 | 150.07 | 156.97 | 203.32 | |
| EV/Net Operating Revenue (X) | 0.67 | 0.67 | 0.60 | 0.79 | 1.06 | |
| EV/EBITDA (X) | 5.72 | 4.62 | 4.17 | 5.76 | 8.14 | |
| MarketCap/Net Operating Revenue (X) | 0.57 | 0.28 | 0.20 | 0.30 | 0.48 | |
| Retention Ratios (%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Price/BV (X) | 1.06 | 0.61 | 0.43 | 0.56 | 0.91 | |
| Price/Net Operating Revenue | 0.57 | 0.28 | 0.20 | 0.30 | 0.48 | |
| Earnings Yield | 0.08 | 0.20 | 0.24 | 0.10 | 0.06 |
23.01.2026
Kopran Consolidated December 2025 Net Sales at Rs 194.28 crore, up 16.87% Y-o-Y
23.01.2026
Kopran Standalone December 2025 Net Sales at Rs 93.88 crore, up 30.51% Y-o-Y
19.11.2025
Kopran Consolidated September 2025 Net Sales at Rs 117.91 crore, down 22.2% Y-o-Y
13.11.2025
Kopran Standalone September 2025 Net Sales at Rs 42.39 crore, down 42.35% Y-o-Y
23.01.2026
Kopran Consolidated December 2025 Net Sales at Rs 194.28 crore, up 16.87% Y-o-Y
23.01.2026
Kopran Standalone December 2025 Net Sales at Rs 93.88 crore, up 30.51% Y-o-Y
19.11.2025
Kopran Consolidated September 2025 Net Sales at Rs 117.91 crore, down 22.2% Y-o-Y
13.11.2025
Kopran Standalone September 2025 Net Sales at Rs 42.39 crore, down 42.35% Y-o-Y
25.03.2026
25.03.2026
25.03.2026
24.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth